Product-Generation Transition Decision Making for Bayer's Hemophilia Drugs: Global Capacity Expansion Under Uncertainty with Supply-Demand Imbalances.
- Published in:
- Operations Research, 2013, v. 61, n. 5, p. 1119, doi. 10.1287/opre.2013.1204
- By:
- Publication type:
- Article